CVS Health Debt Securities, Available-for-Sale, Unrealized Loss Position decreased by 18.2% to $5.44B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 27.0%, from $7.46B to $5.44B. Over 4 years (FY 2020 to FY 2024), Debt Securities, Available-for-Sale, Unrealized Loss Position shows an upward trend with a 95.0% CAGR.
other_debt_securities_available_for_sale_unrealized_loss_ab3ae9| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.07B | $4.39B | $7.38B | $13.55B | $16.92B | $19.46B | $18.49B | $16.95B | $17.66B | $18.18B | $12.55B | $14.24B | $15.00B | $7.46B | $13.24B | $9.90B | $6.65B | $5.44B |
| QoQ Change | — | +43.1% | +68.2% | +83.5% | +24.9% | +15.0% | -5.0% | -8.4% | +4.2% | +2.9% | -31.0% | +13.5% | +5.3% | -50.3% | +77.6% | -25.2% | -32.9% | -18.2% |
| YoY Change | — | — | — | — | +451.6% | +343.2% | +150.4% | +25.1% | +4.4% | -6.6% | -32.1% | -16.0% | -15.0% | -59.0% | +5.5% | -30.5% | -55.7% | -27.0% |